Neural differentiation is essential to human-relevant CNS models, yet variability, immature phenotypes, and inconsistent cell identity can slow research. Better-controlled differentiation strategies are helping teams build more reproducible models.
Human induced pluripotent stem cells (iPSCs) have transformed neuroscience by providing access to disease-relevant neural cells without...
Parkinson's drug discovery is constrained by species differences, patient variability, and imperfect laboratory models. Learn how human iPSC-derived neurons and brain organoids can improve disease modeling and preclinical decisions.
Parkinson's disease research faces a familiar but costly problem: a compound can show promise in a laboratory model yet fail to produce meaningful benefits...
High antibody titers do not always reveal the full quality of vaccine-induced immunity. Explore how liposome-based adjuvants can shape functional responses—and why stability, characterization, and scale-up remain critical hurdles.
For developers of protein subunit and peptide vaccines, selecting a promising antigen is only the beginning. Purified antigens can produce limited...
A 2026 study highlights a drug-delivery challenge: similar lipid particle measurements do not guarantee similar intestinal performance. Emulsion and dry-emulsion developers must also address precipitation, stability, and reproducibility.
Drug developers use lipid-based drug delivery (LDD) to tackle poorly water-soluble compounds, yet a formulation that performs well in initial...
Microfluidic and microneedle technologies promise faster, smaller, and more precise biotech workflows. Yet material selection, fabrication complexity, reproducibility, and slow prototyping still hinder the transition from concept to validation.
Microfluidics has become an important enabling technology for drug discovery, diagnostics, organ-on-a-chip models, biosensing, and...
Microfluidic chips can streamline research, but inconsistent droplets, material incompatibility, and disconnected workflows can waste samples and time. Learn how informed chip selection and system-level validation can improve reliability.
Microfluidic chips can conserve samples and provide precise control over tiny fluid volumes. Yet a device that works during a demonstration may...
Macrophage studies face donor variability, phenotype instability, differences in tissue relevance, and reproducibility challenges. Carefully selected, well-characterized human macrophage models may improve consistency and translational value.
Macrophages are central to inflammation, infection, cancer, fibrosis, tissue repair, and immune regulation. As macrophage-targeted...
Macrophage-targeted therapies offer new opportunities in inflammation and oncology, but variable cell states, limited delivery precision, and weak tissue models can derail development. Here's how integrated assays can support more informed screening decisions.
Macrophages sit at the crossroads of inflammation, tissue repair, and tumor biology. Their plasticity makes them appealing therapeutic...
From Molecule to Antibody: The Impact of Hapten Synthesis on Cadmium Research
The field of antibody development has witnessed significant advancements, particularly with the emergence of novel strategies in hapten design. Haptens, small molecules that can elicit an immune response, play a pivotal role in generating antibodies with high specificity and affinity. This article explores the impact...
Antibodies, the extraordinary proteins that serve as the frontline troops of the human immune system, have recently gained attention for their ability to combat tiny compounds known as haptens. Because of their small size, these elusive targets present particular difficulty for the immune system to identify as foreign invaders. However, researchers' inventiveness has resulted in the creation of...
Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs.
Functional Target Screening: Moving Beyond Binding
Traditional phage display often...
As biopharmaceutical pipelines expand and therapeutic modalities grow more complex, the demand for highly specific, reproducible, and customizable antibodies has never been greater. Two categories—post‑translational modification (PTM)–specific antibodies and anti‑idiotype (anti‑ID) antibodies—have become essential tools for both discovery research and regulated bioanalytical...